Hepatic Src homology phosphatase 2 regulates energy balance in mice

Naoto Nagata1, Kosuke Matsuo, Ahmed Bettaieb

  • 1Department of Nutrition, University of California Davis, Davis, California 95616, USA.

Endocrinology
|May 24, 2012
PubMed

Insights

Deleting the protein tyrosine phosphatase Shp2 in the liver of mice fed a high-fat diet reduced weight gain and improved insulin sensitivity. This highlights Shp2

Area of Science:

  • Metabolic research
  • Molecular biology
  • Endocrinology

Background:

  • The protein tyrosine phosphatase Shp2 regulates hepatic insulin action.
  • Hepatic Shp2 expression increases with high-fat diet (HFD) and decreases with fasting.
  • Its role in lipid metabolism and energy balance under HFD is not fully understood.

Purpose of the Study:

  • To investigate the metabolic effects of liver-specific Shp2 deletion (LSHKO) in mice fed a high-fat diet.
  • To analyze the impact on lipid metabolism, energy balance, and insulin sensitivity.
  • To elucidate the molecular mechanisms underlying these effects.

Main Methods:

  • Generation of liver-specific Shp2-deficient (LSHKO) mice.
  • Feeding LSHKO and control mice a high-fat diet (HFD).
  • Analysis of body mass, lipid metabolism, glucose tolerance, insulin sensitivity, hepatic endoplasmic reticulum stress, inflammation, and mitochondrial respiration.

Main Results:

  • LSHKO mice exhibited reduced weight gain and increased energy expenditure compared to controls on HFD.
  • Hepatic Shp2 deficiency decreased liver steatosis, enhanced insulin suppression of glucose production, and prevented HFD-induced insulin resistance.
  • LSHKO mice showed reduced hepatic ER stress and inflammation, with enhanced STAT3 phosphorylation and increased mitochondrial oxygen consumption.

Conclusions:

  • Hepatic Shp2 is a novel regulator of systemic energy balance during high-fat feeding.
  • Deletion of hepatic Shp2 improves metabolic parameters and insulin sensitivity under HFD conditions.
  • Targeting hepatic Shp2 may offer a therapeutic strategy for metabolic disorders associated with obesity and insulin resistance.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...